What IBD Does to Young Bodies
Inflammatory bowel disease (IBD) — which includes Crohn's disease and ulcerative colitis — is a condition where the immune system mistakenly attacks the digestive tract. It causes pain, diarrhea, fatigue, and inflammation. In the US alone, tens of thousands of children and teenagers live with IBD.
Most people know about the gut symptoms. What fewer people realize is that IBD also puts the whole body on high alert. Chronic inflammation doesn't stay contained — it spills into the bloodstream and other organ systems.
The Risk Adults Already Know About
Doctors have known for years that adults with IBD face a higher risk of venous thromboembolism (VTE) — blood clots that form in deep veins (deep vein thrombosis, or DVT) or travel to the lungs (pulmonary embolism, or PE). These clots can be life-threatening.
But here's the twist: until now, the data on children and teenagers was thin. The assumption was that kids were somehow protected by their youth. This new analysis challenges that assumption directly.
Why Young Blood Clots
Think of chronic inflammation like a fire burning inside blood vessels. The heat from that fire makes the blood "stickier" — more likely to clump together and form clots. IBD creates this inflamed environment persistently, which means the clotting risk doesn't wait for adulthood.
IBD also affects nutrition, causes dehydration during flares, and often leads to hospital stays and reduced activity — all factors that further raise clot risk. Add in some of the medications used for IBD, and you have multiple reasons why a teenager's blood can misbehave.
How the Research Was Done
This systematic review and meta-analysis pooled data from seven large cohort studies covering over 101,000 children and teenagers with IBD. For comparison, the researchers looked at nearly 20 million non-IBD children. The analysis was registered in the PROSPERO database (a public registry for medical reviews), and researchers used rigorous methods to ensure the combined data was reliable.
The Numbers Are Hard to Ignore
The overall finding: children and teens with IBD had nearly 7 times the blood clot risk of those without IBD. For deep vein thrombosis specifically, the risk was about 6 times higher. These are not small statistical differences — they represent a real and measurable danger.
Kids with ulcerative colitis faced the highest risk — about 7.5 times greater than peers without IBD. Those with Crohn's disease had a roughly 3.7 times elevated risk. Both are significant, but the gap between the two conditions is notable and may reflect differences in how each disease affects the body's clotting systems.
This elevated risk is not theoretical — it shows up consistently across multiple studies and hundreds of thousands of patients.
That's Not the Full Story
What makes this finding especially important is that blood clots in children are often missed or dismissed. Symptoms like leg pain or swelling can be chalked up to growing pains or sports injuries. And because clots are considered "adult problems," they may not be on a pediatric team's radar without specific training or guidelines.
Where This Fits in the Bigger Picture
The adult IBD community has clot-prevention protocols — things like blood thinners during hospital stays and awareness campaigns for patients. Pediatric IBD care has been slower to adopt similar approaches. This analysis makes a clear case that the gap needs to close. The researchers explicitly call for VTE prevention strategies to be applied to children and teens, not just adults.
If your child has IBD, ask their gastroenterologist about clot risk — especially during hospital admissions, disease flares, or periods of limited activity. Know the warning signs: unexplained leg pain or swelling, shortness of breath, or chest pain. These symptoms always warrant prompt medical evaluation. You don't need to live in fear, but awareness could make a real difference.
Limitations to Keep in Mind
This analysis combined data from seven studies, which varied in design and how they defined and measured VTE. The overall number of actual clot events in children was still relatively small, which is partly why the confidence intervals (the range of uncertainty around the estimates) were wide. More focused pediatric research is still needed.
Pediatric IBD guidelines will likely need updating to reflect this risk. Researchers are calling for dedicated prospective studies — ones that follow young IBD patients specifically to track clot events and test prevention strategies in children. The hope is that catching and preventing even a small number of life-threatening clots in kids will drive the field toward action sooner rather than later.